For the quarter ending 2025-09-30, PRTA made $2,415,000 in revenue. -$36,541,000 in net income. Net profit margin of -1513.08%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Total revenue | 2,415,000 | 4,420,000 | 2,828,000 | 1,061,500 |
| Research and development | 28,938,000 | 40,517,000 | 50,811,000 | 57,143,000 |
| General and administrative | 13,238,000 | 15,910,000 | 17,598,000 | 17,156,000 |
| Restructuring costs | 479,000 | 32,609,000 | - | - |
| Total operating expenses | 42,655,000 | 89,036,000 | 68,409,000 | 74,299,000 |
| Loss from operations | -40,240,000 | -84,616,000 | -65,581,000 | -73,212,500 |
| Interest income | 3,351,000 | 3,794,000 | 4,348,000 | 6,276,000 |
| Other expense, net | -23,000 | -143,000 | -140,000 | -34,000 |
| Total other income, net | 3,328,000 | 3,651,000 | 4,208,000 | 6,242,000 |
| Loss before income taxes | -36,912,000 | -80,965,000 | -61,373,000 | -66,970,500 |
| Provision for (benefit from) income taxes | -371,000 | 44,802,000 | -1,178,000 | -1,873,000 |
| Net income (loss) | -36,541,000 | -125,767,000 | -60,195,000 | -65,097,500 |
| Basic (in dollars per share) | -0.68 | -2.34 | -1.12 | -1.205 |
| Diluted (in dollars per share) | -0.68 | -2.34 | -1.12 | -1.195 |
| Weighted-average ordinary shares outstanding used in per share calculations- basic (in shares) | 53,830,000 | 53,827,000 | 53,827,000 | -26,892,500 |
| Weighted-average ordinary shares outstanding used in per share calculations- diluted (in shares) | 53,830,000 | 53,827,000 | 53,827,000 | -27,530,500 |
PROTHENA CORP PUBLIC LTD CO (PRTA)
PROTHENA CORP PUBLIC LTD CO (PRTA)